Support: 888-992-3836
Copyright © 2023 InvestorsHub Inc.
Replies to post #546817 on NorthWest Biotherapeutics Inc (NWBO)
SkyLimit2022
12/10/22 12:00 AM
#546821 RE: dr_lowenstein #546817
“Blinatumomab was granted accelerated approval for the treatment of adults and children with B-cell precursor (BCP) acute lymphoblastic leukemia.” “In April 2020, the FDA approved selumetinib for pediatric patients, 2 years of age and older, with neurofibromatosis type 1 (NF1) who have symptomatic, inoperable plexiform neurofibromas”